The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia
Status:
Unknown status
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is exploiting the new drugs for androgenetic alopecia because there
are still no effective and safe topical drug for androgenetic alopecia. Roxithomycin is one
of the macrolide antibiotics that has immunomodulatory effects. We firstly found that
roxithromycin increases the rate of murine and human hair follicle elongation in vitro.
Therefore, we apply this drug on this disease therapy.